TRANSCEND FL: Phase 2 study results of lisocabtagene maraleucel (LISO‐CEL) in patients (pts) with relapsed/refractory (R/R) follicular lymphoma (FL) Meeting Abstract

  


Authors: Morschhauser, F.; Dahiya, S.; Palomba, M. L.; Garcia‐Sancho, A. M.; Reguera Ortega, J. L.; Kuruvilla, J.; Jager, U.; Cartron, G.; Izutsu, K.; Dreyling, M.; Kahl, B.; Ghesquieres, H.; Ardeshna, K.; Goto, H.; Barbui, A. M.; Abramson, J. S.; Borchmann, P.; Fleury, I.; Mielke, S.; Farazi, T.; Fasan, O.; Lymp, J.; Vedal, M.; Nishii, R.; Avilion, A.; Papuga, J.; Nastoupil, L. J.
Abstract Title: TRANSCEND FL: Phase 2 study results of lisocabtagene maraleucel (LISO‐CEL) in patients (pts) with relapsed/refractory (R/R) follicular lymphoma (FL)
Meeting Title: 17th International Conference on Malignant Lymphoma (ICML)
Journal Title: Hematological Oncology
Volume: 41
Issue: Suppl. 2
Meeting Dates: 2023 Jun 13-17
Meeting Location: Lugano, Switzerland
ISSN: 0278-0232
Publisher: Wiley Blackwell  
Date Published: 2023-06-01
Start Page: 877
End Page: 880
Language: English
DOI: 10.1002/hon.3196_LBA4
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:

https://search.ebscohost.com/login.aspx?direct=true&AuthType=ip,shib&db=cin20&AN=164231563&site=ehost-live&scope=site&custid=s2915669
Notes: Meeting Abstract: LBA4 -- Source: Cinahl
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Maria Lia Palomba
    415 Palomba
Related MSK Work